Antibodies taken from alpacas are to be used in a new pandemic flu drug, in a £33 million project led by AstraZenica.

Researchers developed an alpaca-derived antibody that could lead to a cheaper and more effective therapeutic option for the Omicron variant of the novel coronavirus. The team from Kyoto University ...

He explained that what the W25 does is “remove the antibody from the alpaca's immune system, we put it inside the bacteria and what we give is the license so that they can reproduce and study ...